Dr. Lindsey Dawn Goddard, MD

Dr. Goddard practices at Sanford Bemidji Medical Center in Bemidji, Minnesota, part of Sanford Health.

Dr. Goddard's NPI, 1639565872, was assigned on April 14, 2015. Dr. Goddard holds Washington license MD61065973.

Dr. Goddard's primary practice is Sanford Bemidji Medical Center, at 1300 Anne St NW, Bemidji, MN 56601 in Beltrami County. The practice phone is (218) 751-5430.

Dr. Goddard's primary practice is Sanford Bemidji Medical Center in Bemidji, Minnesota, part of Sanford Health. Dr. Goddard is also affiliated with Sanford Broadway Medical Center. The medical group on file is Sanford West Fargo Clinic. Dmand AI also links Dr. Goddard to 1 more hospital, 5 medical groups and 3 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Goddard practices, 6 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Goddard's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dmand AI has Dr. Goddard's licenses on file in 4 states: Washington, Arizona, Idaho and Wisconsin.

CMS data shows 886 Medicare services from Dr. Goddard across 17 procedure codes in 2024, for 391 Medicare patients. Medicare paid $253,389 for them.

CMS counts 391 Medicare patients who saw Dr. Goddard in 2024. The largest group is 75 to 84, with 161 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 4% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Goddard's median patient age at 77, with 40% women.

In 2024, Dr. Goddard wrote 43 Medicare Part D claims for 37 patients. 100% of them were for generic drugs. CMS names the drug for 12 of them, across 1 drug with 11 or more claims each, at $119 in total drug cost. In 2023, CMS named 13 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 97 out of 100 for Dr. Goddard for performance year 2024, reported as part of a group. Dr. Goddard accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 77 procedures of melanoma (skin cancer) excision by Dr. Goddard, more than 91% of the clinicians it reports for that procedure.

Removal of tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 8 papers to Dr. Goddard, published from 2013 to 2020. The most frequent topics are Mohs Surgery, Skin Neoplasms and Antimetabolites, Antineoplastic. Dr. Goddard has published most often in Dermatol Surg. Dr. Goddard's most frequent co-authors are Cameron D. Chesnut, MD, Ruifeng Guo, MD, PhD and Huynh Cao, MD.

CMS Open Payments shows 57 general payments to Dr. Goddard from 18 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 93% of the total. Abbvie Inc. paid the most, $317.